In Silico Bioequivalence – to replace clinical trial
In silico SD Bioequivalence trial to replace clinical trial
In silico SD Bioequivalence trial to replace clinical trial
The Sponsor intended to launch a new generation of a dermal patch already approved and established in the market. The Sponsor had performed a SAD study with the new generation patch.
Could Modeling and Simulation replace the SD BE trial by a SD BE in silico?
SAD PK data of the new patch and SD PK data of the reference were used in the analysis. The in silico SD BE trial was performed by means of parametrized transdermal PBPK modeling.
In silico Quantitative Structure-Toxicity Relationship (QSTR) Model for Predicting Toxicity of Aromatic Aldehydes using Extended Topochemical Atom (ETA) Indices.
In silico clinical trial to support label extension.
Design from Scratch an Influenza Vaccine
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved